Representative(s):

Sarah Donner
Territory Manager
WI, Northern IL, UP of MI
Cell: (608)609-3693
sdonner@deciphera.com

Heidi Litwin
Territory Manager
Chicago
Cell: (312)636-2303
hlitwin@deciphera.com

Kurt Landwehr
Regional Business Director
Central Region
Cell: (314)753-3189
klandwehr@deciphera.com

Rich Wardrop
Director of Field Access
Central
Cell: (314)308-7080
rwardrop@deciphera.com

Dharmesh Bavda
Medical Science Liaison
Chicago
Cell: (847)345-4051
dbavda@deciphera.com

Deciphera Pharmaceuticals
https://www.deciphera.com/

 

Deciphera Pharmaceuticals, a commercial biopharmaceutical company, is decoding cancer at the molecular level by leveraging its proprietary platform to develop a diverse pipeline of drug candidates designed to improve outcomes for patients.  The Company announced its first FDA-approved medicine in May 2020.  Visit our product website at https://qinlockhcp.com/ for more information.

Qinlock (ripretinib) Product Website
https://qinlockhcp.com/

Qinlock Core Claims
PDF icon Qinlock Core Claims - February Update FINAL DCPH-P00390.pdf

Qinlock Management Brochure
PDF icon QINLOCK Management Brochure - Digital - January 2021 Update.pdf

Qinlock (ripretinib) Package Insert
https://qinlockhcp.com/Content/files/qinlock-prescribing-information.pdf

 

Virtual Drop In

March 6th

Click here to join the meeting

Meeting ID: 912 8184 4144
Passcode: 4%+0SM&m